Novavax Inc (NVAX)

Dec 13, 2024, 8:00 AM EST - 5 weeks ago

Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million Milestone

Dec 10, 2024, 8:00 AM EST - 5 weeks ago

Novavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza

Dec 4, 2024, 3:03 AM EST - 6 weeks ago

Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 mln

NVO

Dec 4, 2024, 2:00 AM EST - 6 weeks ago

Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200 Million

Nov 20, 2024, 1:18 PM EST - 2 months ago

Novavax, Inc. (NVAX) Jefferies London Healthcare Conference (Transcript)

Nov 15, 2024, 2:31 PM EST - 2 months ago

Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretary

MRNA PFE LLY

Nov 15, 2024, 12:55 PM EST - 2 months ago

Vaccine Maker Stocks Slump After RFK Jr. Nominated as HHS Head

AZN BNTX LLY MRNA NVO PFE

Nov 15, 2024, 10:40 AM EST - 2 months ago

Vaccine maker stocks fall after conspiracy theory-spreading RFK Jr. tapped to lead health department

MRNA PFE

Nov 15, 2024, 7:47 AM EST - 2 months ago

Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)

Nov 14, 2024, 6:06 PM EST - 2 months ago

Moderna And Other Vaccine Maker Stocks Tumble After Trump Taps RFK Jr. As HHS Head

MRNA PFE

Nov 14, 2024, 4:12 PM EST - 2 months ago

Vaccine maker stocks fall on reports Trump plans to tap RFK Jr. to lead HHS

MRNA PFE BNTX GSK

Nov 13, 2024, 8:00 AM EST - 2 months ago

Novavax to Participate in Jefferies London Healthcare Conference

Nov 13, 2024, 7:30 AM EST - 2 months ago

Novavax Q3 Earnings Disappoint, But A Turnaround May Be Underway

Nov 12, 2024, 11:52 AM EST - 2 months ago

Novavax, Inc. (NVAX) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 11:01 AM EST - 2 months ago

Novavax Stock is Slipping After the Vaccine Maker Cut its Outlook Again

Nov 12, 2024, 10:29 AM EST - 2 months ago

Novavax's stock slides 7% as guidance cut offsets narrower-than-expected third-quarter loss

Nov 12, 2024, 9:44 AM EST - 2 months ago

Novavax Stock Dives Even Though Results Beat Forecasts

Nov 12, 2024, 8:06 AM EST - 2 months ago

Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales

Nov 12, 2024, 8:02 AM EST - 2 months ago

Novavax Reports Third Quarter 2024 Financial Results and Operational Highlights

Nov 11, 2024, 1:25 PM EST - 2 months ago

Novavax Gets FDA Approval To Resume Testing Two Vaccines After Clinical Hold

Nov 11, 2024, 8:41 AM EST - 2 months ago

US FDA lifts clinical hold on Novavax's combo COVID-flu shot

Nov 11, 2024, 8:30 AM EST - 2 months ago

U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial

Nov 5, 2024, 5:15 PM EST - 2 months ago

Novavax, UK terminate vaccine supply agreement

Nov 4, 2024, 4:30 PM EST - 2 months ago

Novavax to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Operational Highlights on November 12, 2024

Oct 30, 2024, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Novavax, Inc. (NVAX) and Encourages Shareholders to Learn More About the Investigation

Oct 29, 2024, 10:00 AM EDT - 2 months ago

Novavax, Inc. (NVAX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Oct 28, 2024, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Novavax, Inc. (NVAX) Shareholders to Inquire about Securities Investigation

Oct 27, 2024, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Novavax, Inc. (NVAX) And Encourages Investors to Connect

Oct 23, 2024, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Novavax, Inc. (NVAX) Stockholders to Inquire about Securities Investigation

Oct 22, 2024, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Novavax, Inc. (NVAX) and Encourages Investors to Learn More About the Investigation

Oct 21, 2024, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Novavax, Inc. (NVAX) And Encourages Investors to Reach Out